Ultreia Capital - Dr Peter Gruss

Dr Peter Gruss, the president of the Max Planck Society, has been appointed to the board of directors at Swiss life science investor Ultreia Capital. In addition Barbara Zink, Ultreia's managing director, has also been appointed to the board. Previous to joining Ultreia, Zink worked at the life science investment team at Lombard Odier Darier Hentsch & Cie.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH